reyesbrian+FollowNovavax Drama: FDA Throws a CurveballThe FDA just hit pause on fully approving Novavax’s COVID-19 vaccine, asking for a whole new clinical trial—even though it’s already been used under emergency authorization. This is the only traditional protein-based COVID shot in the US, and now there’s buzz that ALL vaccines might face stricter rules. Experts are worried this could slow down updates and leave us with outdated shots. Is this just politics or a real safety move? #Novavax #COVID19 #VaccineNews #FDA #HealthDebate #Health31Share
reyesbrian+FollowFDA Drama Over Novavax Vaccine?Big shakeup in the COVID vaccine world: The FDA is suddenly asking Novavax to run a whole new clinical trial before updating its shot, even though it’s been used for years. This move has everyone wondering if Pfizer and Moderna are next. Experts say it could mean endless trials and delays for all future vaccines. Is this about safety, politics, or something else? Stay tuned—this could get messy! #Novavax #COVID19 #FDA #VaccineUpdate #HealthNews #Health60Share
Allison Bauer+FollowFDA Drama Over Novavax COVID ShotThe FDA is making Novavax jump through new hoops for its COVID vaccine, even though it’s already been proven in a massive trial. Now, there’s buzz that all COVID shots (not just Novavax) might face tougher approval rules, which could slow down updates. Experts are worried this could mean endless clinical trials and outdated vaccines. Is this about safety, or just politics? The plot thickens! #Novavax #COVID19 #VaccineUpdate #FDA #HealthNews #Health31Share
Stephanie Snow+FollowNovavax Side Effects: The Real TeaJust saw a study comparing the new Novavax COVID shot to Pfizer’s mRNA one—turns out Novavax had way fewer and milder side effects! Healthcare workers and first responders in the US said Novavax was less likely to mess with their day or work. The difference? Fewer symptoms, less severity, and less disruption. It’s not a perfect study, but if you’re worried about side effects, this might be worth asking your doc about. More data = better choices! #Novavax #COVID19 #VaccineUpdate #HealthNews #Science #Health50Share
Michelle Chen+FollowNovavax Drama: What’s Up With FDA?The FDA is throwing a curveball at Novavax, the only traditional protein-based COVID vaccine in the US, by demanding a new clinical trial before full approval. This surprise move has everyone wondering if Pfizer and Moderna are next in line for extra hoops. With shifting policies and political drama, the future of COVID shots just got a lot murkier. Anyone else getting déjà vu from the early vaccine days? #Novavax #COVID19 #VaccineNews #FDA #HealthDebate #Health20Share
suarezpatricia+FollowNovavax’s Big FDA Moment?Novavax’s COVID vaccine might finally get full FDA approval soon! It’s the only protein-based shot left in the US, and right now it’s just emergency use. The FDA wants more data, but Novavax is hustling to get it done. If they get the green light, their vaccine could stick around even after health emergencies end. Wild how much drama goes on behind the scenes with these approvals! #Novavax #COVID19 #VaccineNews #FDA #HealthUpdate #Health20Share
Christian Boone+FollowNovavax’s Big FDA Moment?Novavax’s COVID shot might finally get full FDA approval—making it the only protein-based vaccine sticking around in the U.S. for the long haul. Unlike Pfizer and Moderna’s mRNA shots, Novavax uses a more old-school approach (think: lab-grown spike proteins). The FDA just wants a bit more data before giving the green light. If approved, Novavax could stay on shelves even after health emergencies end. Did you know this vaccine is still in the game? #Novavax #COVID19 #VaccineNews #FDAApproval #HealthUpdate #Health61Share
Stephanie Snow+FollowNovavax Vax Drama: Patients Push BackFDA’s dragging its feet on approving the Novavax COVID booster, and people who can’t (or won’t) take mRNA shots are NOT having it. Patients with long COVID are rallying, flooding the CDC with comments and hunting down the last doses before they expire. The FDA says it’ll consider approval if Novavax coughs up more data, but folks are worried their only non-mRNA option could disappear. The vaccine debate just got way more personal! #Novavax #COVID19 #VaccineChoice #LongCOVID #FDA #Health80Share
